#TITLE_ALTERNATIVE#
Nimotuzumab is a humanized monoclonal antibody (mAb) that its uses has more <br /> <br /> <br /> <br /> <br /> advantages when compared with another mAb that targeting RGFR, because it does <br /> <br /> <br /> <br /> <br /> not...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/19568 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Nimotuzumab is a humanized monoclonal antibody (mAb) that its uses has more <br />
<br />
<br />
<br />
<br />
advantages when compared with another mAb that targeting RGFR, because it does <br />
<br />
<br />
<br />
<br />
not cause side effects such as skin rash. The combination with radiotherapy shown to <br />
<br />
<br />
<br />
<br />
improve the therapeutic effect, therefore nimotuzumab had been developed as a <br />
<br />
<br />
<br />
<br />
radiopharmaceutical therapy. In preparation, nimotuzumab often conditioned in a <br />
<br />
<br />
<br />
<br />
various of environments with a variation of pH, temperature and the presence of other <br />
<br />
<br />
<br />
<br />
compounds. In this research, molecular dynamics simulations have been carried out <br />
<br />
<br />
<br />
<br />
to study the structure of nimotuzumab due to the effect of temperature, and also <br />
<br />
<br />
<br />
<br />
steered molecular dynamics (SMD) simulation to study the stability of nimotuzumab <br />
<br />
<br />
<br />
<br />
as a result of external forces. Simulations were performed using the Not Just Another <br />
<br />
<br />
<br />
<br />
Molecular Dynamic (NAMD) program and analysis was performed with the Visual <br />
<br />
<br />
<br />
<br />
Molecular Dynamics (VMD) program. From the analysis of Root Mean Square <br />
<br />
<br />
<br />
<br />
Displacement (RMSD) over a span of molecular dynamics simulations for 900 ps, <br />
<br />
<br />
<br />
<br />
RMSD values obtained at temperatures of 277 K, 310 K, 353 K and 373 K are 2,37; <br />
<br />
<br />
<br />
<br />
2,50; 2,46 and 2,53 respectively. Analysis of stability per residue on the heavy chain <br />
<br />
<br />
<br />
<br />
showed that the active site CDR3 region that is at residues numbered 98 (tryptophan) <br />
<br />
<br />
<br />
<br />
and 99 (phenyl alanine) has the biggest conformational changes. On the light chain, <br />
<br />
<br />
<br />
<br />
the changes occur at residues numbered 1 (aspartat), 127 (serin), and 186 (tyrosine), <br />
<br />
<br />
<br />
<br />
that none of that residues is a part of active site or CDRs region from the light chain. <br />
<br />
<br />
<br />
<br />
Steered Molecular Dynamics (SMD) simulation were carried out by fixing the Nterminal <br />
<br />
<br />
<br />
<br />
end of the heavy chain and applying external forces to the C-terminal end. <br />
<br />
<br />
<br />
<br />
The pulling made at a constant velocity of 0.5 Å/ps. Force peak arising at the start of <br />
<br />
<br />
<br />
<br />
the unfolding process is 1226 pN. This force allegedly caused by the rupture of <br />
<br />
<br />
<br />
<br />
hydrogen bonds between heavy chain residues VAL211 and heavy chain residues <br />
<br />
<br />
<br />
<br />
TYR 194. |
---|